Actively Recruiting
Magnetic Imaging for Diagnostic of Amyotrophic Lateral Sclerosis
Led by University Hospital, Toulouse · Updated on 2024-08-02
50
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Nearly 60% of Amyotrophic Lateral Sclerosis (ALS) patients have a low level of diagnostic certainty (possible, probable) at the time of diagnosis. In the absence of biomarkers, this diagnosis is based, among other things, on the demonstration of the diffusion of signs of denervation by electroneuromyography (ENMG). The objective of this study is to improve the earliness and the level of diagnostic certainty by better demonstrating the diffusion of the denervation process by whole body muscular MRI.
CONDITIONS
Official Title
Magnetic Imaging for Diagnostic of Amyotrophic Lateral Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed consent form from the patient
- Suspected ALS defined by Awaji Shima criteria (possible, probable, defined)
- Clinical evidence of upper motor neuron involvement
- Electrophysiologic evidence of lower motor neuron involvement
You will not qualify if you...
- Unable to give informed consent
- Contraindication to MRI
- Respiratory failure preventing lying flat in the scanner
- Under judicial protection or another protective regime
- Female who is pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pascal CINTAS
Toulouse, France, 31000
Actively Recruiting
Research Team
P
Pascal CINTAS, MD PHD
CONTACT
A
Anne Cecile Coville
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here